ArticleAustralian veterinary journal
Single-dose Pasteurella multocida and Histophilus somni autogenous vaccines administered at induction significantly improved feedlot cattle performance and profitability in Australia.
Article in Australian veterinary journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBovine respiratory disease (BRD) is the most economically important disease affecting feedlot cattle. While viral pathogens are initiating agents, bacterial coinfections exacerbate disease severity. Vaccines for Pasteurella multocida and Histophilus somni are not commercially available in Australia.
methodsThis trial evaluated the efficacy of a single-dose autogenous vaccine targeting P. multocida and H. somni, administered intramuscularly at induction, on carcase characteristics, feed conversion efficiency and health performance in feedlot cattle.
resultsVaccinated cattle showed a 6.20% lower prevalence of subclinical BRD than controls (16.50% vs. 22.70%), corresponding to a 27.31% lower likelihood of subclinical BRD with vaccination. Vaccinated cattle exhibited improved performance, with a 2.86% increase in average daily gain, a 0.50% increase in hot standard carcase weight, a 0.81% increase in loin eye muscle area and a 2.68% increase in dry matter intake compared with controls. Vaccinated cattle showed lower odds of lung consolidation compared with controls (odds ratio [OR] = 0.73), indicating a 27.00% reduction in the likelihood of consolidation. Similarly, vaccinated cattle showed a 35.50% reduction in pleurisy scores relative to controls (OR = 0.65). Despite slightly higher feedlot costs, vaccinated cattle achieved a higher total end value and higher gross profit margins with a cost-benefit ratio of 6.95.
conclusionsGiven the overall reduced BRD incidence during the study period, the observed results may be influenced by pathogen prevalence, vaccine dosage, timing, route of administration and environmental factors. While the single-dose vaccine improved subclinical disease outcomes and growth performance, further studies, including a two-dose vaccine trial, are required to assess the full potential of the anamnestic immune response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.